OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Tailored horseshoe-shaped nicotinonitrile scaffold as dual promising c-Met and Pim-1 inhibitors: Design, synthesis, SAR and in silico study
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
Samy Mohamady, Ahmed Khalil, Bassem H. Naguib, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106988-106988
Closed Access | Times Cited: 9
Showing 9 citing articles:
Recent advances in c-Met-based dual inhibitors in the treatment of cancers
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 9
Fanqi Jin, Yi‐Han Lin, Yuan Weidong, et al.
European Journal of Medicinal Chemistry (2024) Vol. 272, pp. 116477-116477
Closed Access | Times Cited: 9
Discovery of novel tris-1,2,3-triazole-based hybrids as VEGFR2 inhibitors with potent anti-proliferative and cytotoxicity through apoptosis induction
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
Mosa Alsehli, Adeeb Al Sheikh Ali, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108131-108131
Closed Access
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 5
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 5
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 2
Discovery of new 1,3-diphenylurea appended aryl pyridine derivatives as apoptosis inducers through c-MET and VEGFR-2 inhibition: design, synthesis, in vivo and in silico studies
Heba A. Elsebaie, Mohamed S. Nafie, Haytham O. Tawfik, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2553-2569
Closed Access | Times Cited: 1
Heba A. Elsebaie, Mohamed S. Nafie, Haytham O. Tawfik, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 7, pp. 2553-2569
Closed Access | Times Cited: 1
Fragment-based design and synthesis of coumarin-based thiazoles as dual c-MET/STAT-3 inhibitors for potential antitumor agents
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Bassem H. Naguib, Heba A. Elsebaie, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107682-107682
Closed Access | Times Cited: 1
Cancer research in the United Arab Emirates from birth to present: A bibliometric analysis
Humaid O. Al‐Shamsi, Siddig İbrahim Abdelwahab, Osama Albasheer, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27201-e27201
Open Access
Humaid O. Al‐Shamsi, Siddig İbrahim Abdelwahab, Osama Albasheer, et al.
Heliyon (2024) Vol. 10, Iss. 6, pp. e27201-e27201
Open Access
Current scenario of pyrazole hybrids with anti‐breast cancer therapeutic applications
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Mengyu Ma
Archiv der Pharmazie (2024) Vol. 357, Iss. 10
Closed Access
Synthesis of novel pyridine and pyrazolyl pyridine conjugates with potent cytotoxicity against HepG2 cancer cells as PIM-1 kinase inhibitors and caspase activators
Mohamed S. Nafie, Ahmed Hamza, Ahmed H. Moustafa, et al.
RSC Advances (2024) Vol. 14, Iss. 53, pp. 39381-39394
Open Access
Mohamed S. Nafie, Ahmed Hamza, Ahmed H. Moustafa, et al.
RSC Advances (2024) Vol. 14, Iss. 53, pp. 39381-39394
Open Access
